Pliant Therapeutics (PLRX) Other Non-Current Liabilities (2019 - 2021)

Pliant Therapeutics (PLRX) has 3 years of Other Non-Current Liabilities data on file, last reported at $756000.0 in Q3 2021.

• Other Non-Current Liabilities for Q3 2021 came in at $756000.0, up 96.88% year-over-year; the trailing twelve-month figure through Sep 2021 was $756000.0 (up 96.88% YoY), and the FY2020 annual result was $866000.0, up 95.05% from the prior year.
• Other Non-Current Liabilities eased to $756000.0 in Q3 2021 per PLRX's latest filing, from $804000.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $951000.0 in Q2 2020 and troughed at $384000.0 in Q3 2020.
• A 3-year average of $720000.0 and a median of $804000.0 in 2021 frame the typical range for Other Non-Current Liabilities.
• On a YoY basis, Other Non-Current Liabilities climbed as much as 96.88% in 2021 and fell as far as 15.46% in 2021.
• A 3-year view of Other Non-Current Liabilities shows it stood at $444000.0 in 2019, then jumped by 95.05% to $866000.0 in 2020, then fell by 12.7% to $756000.0 in 2021.
• Business Quant data shows PLRX's Other Non-Current Liabilities at $756000.0 in Q3 2021, $804000.0 in Q2 2021, and $835000.0 in Q1 2021.